Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2507

1.

Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation - real-life data from a survey in Eastern Switzerland.

Maeder MT, König T, Bogdanovic S, Schneider I, Eugster W, Ammann P, König M, Beer J, Rickli H.

Swiss Med Wkly. 2017 Oct 17;147:w14503. doi: 10.4414/smw.2017.14503. eCollection 2017 Oct 17.

2.

Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure.

Hohendanner F, Heinzel FR, Blaschke F, Pieske BM, Haverkamp W, Boldt HL, Parwani AS.

Heart Fail Rev. 2017 Oct 16. doi: 10.1007/s10741-017-9657-9. [Epub ahead of print] Review.

PMID:
29038991
3.

Right Ventricular Pacing: Can More of a Bad Thing Be Good?

Zarraga IGE, Jessel PM, Raitt MH.

Circ Arrhythm Electrophysiol. 2017 Oct;10(10). pii: e005816. doi: 10.1161/CIRCEP.117.005816. No abstract available.

PMID:
29030382
4.

Medication Review and Transitions of Care: A Case Report of a Decade-Old Medication Error.

Comer R, Lizer M.

Consult Pharm. 2017 Oct 1;32(10):7-12. doi: 10.4140/TCP.n.2015.130.

PMID:
29021008
5.

Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation.

Chang SH, Chou IJ, Yeh YH, Chiou MJ, Wen MS, Kuo CT, See LC, Kuo CF.

JAMA. 2017 Oct 3;318(13):1250-1259. doi: 10.1001/jama.2017.13883.

PMID:
28973247
6.

Efficacy and safety of dronedarone in the treatment of patients with atrial fibrillation.

Khan MH, Rochlani Y, Aronow WS.

Expert Opin Drug Saf. 2017 Dec;16(12):1407-1412. doi: 10.1080/14740338.2017.1387246. Epub 2017 Oct 6.

PMID:
28960089
7.

Management of amiodarone extravasation with intradermal hyaluronidase.

Fox AN, Villanueva R, Miller JL.

Am J Health Syst Pharm. 2017 Oct 1;74(19):1545-1548. doi: 10.2146/ajhp160737.

PMID:
28947526
8.

Evaluation of amiodarone versus metoprolol in treating atrial fibrillation after coronary artery bypass grafting.

Kamali A, Sanatkar A, Sharifi M, Moshir E.

Interv Med Appl Sci. 2017 Jun;9(2):51-55. doi: 10.1556/1646.9.2017.2.11.

9.

Current practice in the management of new-onset atrial fibrillation in critically ill patients: a UK-wide survey.

Chean CS, McAuley D, Gordon A, Welters ID.

PeerJ. 2017 Sep 8;5:e3716. doi: 10.7717/peerj.3716. eCollection 2017.

10.

Prevalence, predictors, and prognostic implications of PR interval prolongation in patients with heart failure.

Nikolaidou T, Pellicori P, Zhang J, Kazmi S, Goode KM, Cleland JG, Clark AL.

Clin Res Cardiol. 2017 Sep 15. doi: 10.1007/s00392-017-1162-6. [Epub ahead of print]

PMID:
28917011
11.

Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.

Rowin EJ, Hausvater A, Link MS, Abt P, Gionfriddo W, Wang W, Rastegar H, Estes NAM 3rd, Maron MS, Maron BJ.

Circulation. 2017 Sep 15. pii: CIRCULATIONAHA.117.029267. doi: 10.1161/CIRCULATIONAHA.117.029267. [Epub ahead of print]

PMID:
28916640
12.

Severe Thyrotoxicosis Secondary to Povidone-Iodine from Peritoneal Dialysis.

Lithgow K, Symonds C.

Case Rep Endocrinol. 2017;2017:2683120. doi: 10.1155/2017/2683120. Epub 2017 Aug 24.

13.

Delayed Onset of Atrial Fibrillation and Ventricular Tachycardia after an Automobile Lightning Strike.

Drigalla D, Essler SE, Stone CK.

J Emerg Med. 2017 Nov;53(5):740-745. doi: 10.1016/j.jemermed.2017.06.038. Epub 2017 Sep 4.

PMID:
28882638
14.

Natriuretic Propeptides as Markers of Atrial Fibrillation Burden and Recurrence (from the AMIO-CAT Trial).

Darkner S, Goetze JP, Chen X, Henningsen K, Pehrson S, Svendsen JH.

Am J Cardiol. 2017 Oct 15;120(8):1309-1315. doi: 10.1016/j.amjcard.2017.07.018. Epub 2017 Jul 24.

PMID:
28865890
15.

Atrial Fibrillation in Heart Failure US Ambulatory Cardiology Practices and the Potential for Uptake of Catheter Ablation: An National Cardiovascular Data Registry (NCDR<sup>®</sup>) Research to Practice (R2P) Project.

Mathew JS, Marzec LN, Kennedy KF, Jones PG, Varosy PD, Masoudi FA, Maddox TM, Allen LA.

J Am Heart Assoc. 2017 Aug 11;6(8). pii: e005273. doi: 10.1161/JAHA.116.005273.

16.

Pulmonary embolism four days after interruption of therapy with rivaroxaban.

Göndör G, Stöllberger C.

Hamostaseologie. 2017 Oct 26;37(4):302-306. doi: 10.5482/HAMO-17-01-0005. Epub 2017 Aug 24.

PMID:
28853765
17.

The role of radiopharmaceuticals in Amiodarone-induced thyroid pathology.

Piciu D, Irimie A.

Curr Radiopharm. 2017 Aug 16. doi: 10.2174/1874471010666170816125402. [Epub ahead of print]

PMID:
28814251
18.

Rapid onset of amiodarone induced pulmonary toxicity after lung lobe resection - A case report and review of recent literature.

Baumann H, Fichtenkamm P, Schneider T, Biscoping J, Henrich M.

Ann Med Surg (Lond). 2017 Jul 19;21:53-57. doi: 10.1016/j.amsu.2017.07.034. eCollection 2017 Sep.

19.
20.

Influence of renal function on anticoagulation control in patients with non-valvular atrial fibrillation taking vitamin K antagonists.

Lobos-Bejarano JM, Castellanos Rodríguez A, Barrios V, Escobar C, Polo-García J, Del Castillo-Rodríguez JC, Vargas-Ortega D, Lopez-Pineda A, Prieto-Valiente L, Lip GYH; PAULA Study Team.

Int J Clin Pract. 2017 Sep;71(9). doi: 10.1111/ijcp.12974. Epub 2017 Jul 19.

PMID:
28722795

Supplemental Content

Loading ...
Support Center